Systematic Reviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3634-3648
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3634
Table 3 Characteristics of preclinical experiments on large animals in past 10 years
IDYearAnimal
BAL system
Outcomes
Test for PERV
SpeciesNoSexWeight(kg)InducerTypeCellMassBioreactorTreatment timeSurvivalOther
192011Pig30M10-15D-galactosamineFBBALAlginate-chitosan encapsulated primary porcine hepatocytes5 × 109Choanoid fluidized bed bioreactor6 hSurvival time: BAL 72.9 ± 4.72 h Sham BAL 54.6 ± 4.09 h Control 54.8 ± 3.98 hDecreased: lactate; glucoseNR
202012Canine32NR10-15D-galactosamineHBALCo-cultured porcine hepatocytes and bone marrow mesenchymal stem cells1x 1010Multi-layer flat-plate bioreactor + anionic resin adsorption column3 h7 day survival: HBAL 7/8 BAL 5/8 NBAL 4/8 Control 3/8Decreased: transaminases; LDH; ammonia; bilirubin; PT Increased: ALBNegative (7 d)
212013Pig13F25-30Hepaticartery ligationNAAlginate-encapsulated HepG2cell-spheroids5 × 1010Fluidised-bed bioreactor7 hSurvival time: BAL 10.5 ± 20.7 h SBAL 8.6 ± 21.4 hDecreased: ICP; ammonia; Increased: bilirubin; acidosisNR
222014Cynomolgus monkey15M6.5-7.0D-galactosamineHBALSSHuman hepatic CL-1 cells grown in microgravity culture4 × 109Perfusion bioreactor6 hSurvival time: 128 h BAL 5/10 Control 0/5Decreased: bilirubin; TBA; BUN; Cr; ammonia; Fischer indices Increased: ALBNR
232015Canine8NR10-13D-galactosamineHBALCo-cultured porcine hepatocytes and bone marrow mesenchymal cells1 × 1010Multi-layer flat-plate bioreactor + anionic resin adsorption column6 h1 year survival: 7/8Decreased: transaminases; PT; bilirubin; LDH; ammonia; Increased: ALBNegative (1 year)
242015Pig18F45D-galactosamineSRBALPorcine hepatocytes spheroids200 gSpheroid reservoir24 hSurvival 90 h (%) ST 0/6, 0% ST + Non-cell 1/6,17% ST + SRBAL 5/6, 83%Decreased: ammonia; ICP; brain water contentNR
252016Pig21M10-15D-galactosamineFBBALAlginate-chitosan encapsulated porcine hepatocytes5 × 109Choanoid fluidized bed bioreactor6hSurvival time: FBBAL 70.4 ± 11.5 h Sham FBBAL 51.6 ± 7.9 h Control 49.3 ± 6.6 hDecreased: PCs; LPCs; FAs; SM; Increased: CBAsNR
262016Pig20NR15-25D-galactosamineHiHep-BALHiHeps3 × 109Multi-layer radial-flow bioreactor3hSurvival 7 d: hiHep-BAL 7/8 Empty-BAL 1/6 No-BAL 0/6Decreased: transaminase ammonia; bilirubin; PTNR
272017Pig25F30-35Surgical ligation of all blood flow to the liverUCLBAL3-dimensional (3D) HepG2-cell spheroids7.3 × 1010Fuidised bed bioreactor6hSurvival time: Control-BAL 7.04 ± 1.9h, n = 15 Cell-BAL 8.21 ± 2.3 h, n = 13Decreased: PT; INR; ICP; ammoniaNR
282017Pig15M45-55Complete hepatic inflow devascularizationNACa-alginate-immobilized hepatocyte spheroids2 × 1010Packed-bed bioreactor12hMedian survival time: Control 21 h n = 5 BAL 28.5 h n = 5 Cell-free BAL 21 h n = 5Decreased: ammonia; creatinine ICP; BP Increased: urineNR
292018Rhesus monkey30M10-20α-amanitin and lipopolysaccharideSRBALPig hepatocyte-HUVEC organoids2.6 × 1010Spheroid reservoir6 hMedian survival time: SRBAL 12 h 336 h n = 6 SRBAL 24 h 248 h n = 6 SRBAL 36 h 132 h n = 6 Sham no-cell SRBAL 12 h 90 h n = 6 Control 60.5 h n = 6Decreased: ammonia; bilirubin Increased: albuminNegative (6 h)
302019Pig18F20-3085% hepatectomySRBALPorcine hepatocyte spheroids200gSpheroid reservoir24 hSurvival rate at 90 h: SMT 0/6 SMT plus no-cell SRBAL 0/6 SMT plus SRBAL (200 g) 5/6Decreased: ammonia; ICP; INR Increased: volume regenerationNR